Home > Boards > US Listed > Medical - Drugs > Dr. Reddy's Laboratories Limited (RDY)

Source: IRIS (05 May 2008)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
buhg1b Member Profile
 
Followed By 8
Posts 737
Boards Moderated 0
Alias Born 05/03/07
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/1/2020 9:01:20 AM
Dr. Reddy’s Partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a Potential Treatment of COVID-19 Business Wire - 7/1/2020 4:10:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/29/2020 7:26:11 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/25/2020 3:05:33 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/23/2020 2:05:50 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/19/2020 10:09:58 AM
Dr. Reddy's Laboratories announces the launch of Abiraterone Acetate Tablets USP, 250 mg in the U.S. Market Business Wire - 6/19/2020 5:39:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/16/2020 8:05:04 AM
Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F Business Wire - 6/16/2020 1:48:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/15/2020 8:21:09 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/15/2020 7:53:42 AM
Dr. Reddy's Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir Business Wire - 6/13/2020 5:15:00 AM
Dr. Reddy's Laboratories Announces the Launch of Colchicine Tablets USP, 0.6 mg in the U.S. Market Business Wire - 6/12/2020 7:44:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/10/2020 8:23:55 AM
Dr. Reddy’s Laboratories Completes the Acquisition of Select Business Divisions of Wockhardt Business Wire - 6/10/2020 5:49:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/1/2020 7:47:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/28/2020 7:17:59 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/22/2020 9:10:34 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/21/2020 7:14:33 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/21/2020 6:29:32 AM
Dr. Reddy’s Q4 & FY20 Financial Results Business Wire - 5/20/2020 6:45:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/18/2020 7:35:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/13/2020 6:36:24 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/8/2020 9:54:27 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/8/2020 9:41:55 AM
buhg1b   Monday, 05/05/08 11:21:54 AM
Re: None
Post # of 18 
Source: IRIS (05 May 2008)

Dr Reddy`s Laboratories allotted 2,870 equity shares of Rs 5 each of the company on May 03, 2008, to company employees under the Dr. Reddy`s Employees Stock Option Scheme, 2002.

In addition, the compensation committee of the board of directors of the company has allotted 17,604 ADRs of Rs 5 each on May 03, 2008, to the US employees of the company under Dr. Reddy`s Employees ADR Stock Option Scheme, 2007.

Dr. Reddy`s is a vertically integrated, global pharmaceutical company with proven research capabilities and presence across the pharmaceutical value chain. It manufactures active pharmaceutical ingredients (APIs) and finished dosage forms and markets them globally, with a focus on United States, Europe, India and Russia.

Shares of the company gained Rs 6, or 0.95%, to settle at Rs 638.45. The total volume of shares traded was 31,724 at the BSE (Monday).

http://www.myiris.com/newsCentre/newsPopup.php?fileR=20080505180745181&dir=2008/05/05&secID=livenews

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist